Gene Editing Study finds significant evidence for inaccurate and misleading labeling of CBD content Posted on July 20, 2022 by Editorial Staff In a new study, Johns Hopkins Medicine researchers tested more than 100 topical cannabidiol (CBD) products available online and at retail stores, and found significant evidence of inaccurate and misleading labeling of CBD content. Share on FacebookTweetFollow us Editorial Staff Novel blood test offers unprecedented insight into a patient’s cancer make-up Wearable activity trackers are effective in increasing physical activity and improving health